Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) has announced that Dr Rick Strassman, author of the book 'DMT: The Spirit Molecule' and an Algernon consultant, will join the company's CEO Christopher J. Moreau for the Science Keynote Address at the Wonderland conference in Miami.
Algernon is the Headline Sponsor for the conference, a world-leading event in the psychedelic medicine industry, to be held from November 3-5, 2022 at the Mana Wynwood Convention Centre. The keynote address will review the positive pre-clinical science and data driving the company's pioneering Phase 1 clinical study of DMT for the treatment of stroke and will take place on November 5, 2022, at 2.00pm ET.
Southern Silver Exploration Corp (TSX-V:SSV, OTCQX:SSVFF) said it has filed on SEDAR its National Instrument 43-101 Technical Report titled Preliminary Economic Assessment of the Cerro Las Minitas Project, Durango State, Mexico, dated October 13, 2022. The report was authored by M3 Engineering & Technology Corp, Kirkham Geosystems Ltd. (KGL), Entech Mining Limited, and Metallurgical Process Consultants Limited (MPC). Filing of the Technical Report follows Southern Silver's news release issued August 29, 2022 announcing the results of its Preliminary Economic Assessment (PEA) on its 100% owned Cerro Las Minitas Project, Durango State, Mexico
Nextech AR Solutions Corp. (CSE:NTAR, OTCQB:NEXCF) said it has now received approval at the annual and special meeting of shareholders of the company held on October 12, 2022, to proceed with its proposed plan of arrangement under the Business Corporations Act (British Columbia) to spinout its ARway platform and associated assets to Nextech’s wholly-owned subsidiary 1000259749 Ontario Inc. As previously announced, the arrangement will result in, among other things, Nextech receiving an aggregate of 16,000,000 common shares of ARway and an aggregate of 4,000,000 ARway shares being distributed directly to the shareholders of Nextech on a pro-rata basis, all under an arrangement agreement dated effective July 29, 2022, between 1000259749 Ontario Inc and a special purpose financing company, 1373222 B.C. Ltd.
BioVaxys Technology Corp. (CSE:BIOV, OTCQB:BVAXF) has announced that, further to its news release dated October 6, 2022, it has settled an aggregate of $300,000 in debt through the issuance of common shares issued at a deemed price of $0.15 per common share.
Biocept Inc (NASDAQ:BIOC) has announced that it will be holding an hour-long webinar at 1.00pm EST today, October 14, 2022, featuring case studies presented by leading neuro-oncologists who have used the company's CNSide assay in the management of patients with confirmed or suspected central nervous system metastasis. Participants can pre-register or register at webinar start time here. The webinar will be available live and archived at www.biocept.com.